Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.1%

99 terminated/withdrawn out of 983 trials

Success Rate

83.8%

-2.7% vs industry average

Late-Stage Pipeline

15%

143 trials in Phase 3/4

Results Transparency

10%

52 of 514 completed trials have results

Key Signals

112 recruiting52 with results54 terminated45 withdrawn

Enrollment Performance

Analytics

N/A

573(69.8%)

Phase 3

87(10.6%)

Phase 2

59(7.2%)

Phase 4

56(6.8%)

Phase 1

35(4.3%)

Early Phase 1

11(1.3%)

821Total

N/A(573)

Phase 3(87)

Phase 2(59)

Phase 4(56)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (983)

Showing 20 of 983 trials

NCT07244211Not ApplicableRecruiting

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Role: collaborator

NCT05615844Phase 3Recruiting

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

Role: collaborator

NCT06119048Not ApplicableCompleted

Phe for Me? The Effects of L-Phe on PKU Carriers and Non-carriers

Role: collaborator

NCT05151900Not ApplicableCompleted

Implementing Virtual Parent Support Groups for Eating Disorders Across Canada

Role: lead

NCT02965313Not ApplicableActive Not Recruiting

Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial

Role: collaborator

NCT07533864Recruiting

ACSS Approach on Dysphagia

Role: collaborator

NCT06296849Phase 2Recruiting

Dyadic Financial Incentive Treatments for Dual Smoker Couples

Role: collaborator

NCT07554950Not ApplicableNot Yet Recruiting

Evaluating the Impact of Psychoeducation and Sleep-informed Workshop Targeting Sleep Concerns in Women and Individuals With Premenstrual Dysphoric Disorder

Role: collaborator

NCT06421675Phase 2Recruiting

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

Role: collaborator

NCT07546955Not Yet Recruiting

AI-Enhanced Wide-Field Endoscopic Fluorescence Mapping of Gastrointestinal Mucosal Permeability in IBD - A Pilot Study in IBD Patients and Controls

Role: collaborator

NCT07096661Enrolling By Invitation

Pain Science Education for Labour and Postpartum Pain

Role: collaborator

NCT05610319Phase 4Active Not Recruiting

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Role: lead

NCT06896175Not ApplicableRecruiting

Effect of Ilex Paraguariensis Harvest Time and Consumption Method of Processed Yerba Mate on the Lipid Profile

Role: collaborator

NCT04670016Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Role: collaborator

NCT07300579Not Yet Recruiting

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2

Role: collaborator

NCT04364750Early Phase 1Completed

Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome